Transgenerational effects of neonatal hypoxia-ischemia in progeny von Infante, Smitha K., Rea, Harriett C., Perez-Polo, J.R.

Volltext

Inflammatory Consequences in a Rodent Model of Mild Traumatic Brain Injury von Perez-Polo, J. Regino, Rea, Harriet C., Johnson, Kathia M., Parsley, Margaret A., Unabia, Geda C., Xu, GuoJing, Infante, Smitha K., DeWitt, Douglas S., Hulsebosch, Claire E.

Volltext

PCN292 CURRENT AND FUTURE EU5 PAYER LANDSCAPE FOR ONCOLOGY SOMATIC MUTATION PANELS von Carlow, D., Infante, K.

Volltext

PCN120 Clinical and Economic Consequences of Delayed Care Due to the COVID-19 Pandemic- Focus on Mammograms and Breast Cancer von Infante, K., Eslami, N., Garfield, S.

Volltext

Inflammatory consequences in a rodent model of mild traumatic brain injury von Perez-Polo, J Regino, Rea, Harriet C, Johnson, Kathia M, Parsley, Margaret A, Unabia, Geda C, Xu, Guojing, Infante, Smitha K, Dewitt, Douglas S, Hulsebosch, Claire E

Volltext

Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015 von Ansari, W, Infante, K

Volltext

PCN231 - Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015 von Ansari, W, Infante, K

Volltext

PMU59 GLOBAL OUTCOMES-BASED CONTRACTING TRENDS IN THE US AND EUROPE OVER THE PAST 5 YEARS von Infante, K., Eslami, N., Garfield, S.

Volltext

PNS94 2018 AND 2019 OUTCOMES BASED CONTRACTING TRENDS EXPLORED BY TA, PAYER TYPE AND RISK SHARING MECHANISM IN THE US von Infante, K., Eslami, N., Garfield, S.

Volltext

PCN405 ADOPTION AND UPTAKE OF LIQUID BIOPSY-BASED NSCLC SOMATIC MUTATION TESTING IN THE EU5 CLINICAL SETTING von Carlow, D., Infante, K., Homer, C.

Volltext

PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World von Hildreth, C., Infante, K., Eslami, N., Garfield, S.

Volltext

PBI33 CAN INNOVATIVE PAYMENT REFORM BE THE SOLUTION TO ADDRESS REIMBURSEMENT AND UPTAKE CHALLENGES FOR CAR-T THERAPIES? von Infante, K., Madhavan, P., Stojanovic, I., Kaur, S., Nash, C.

Volltext

PCN197 CURRENT AND FUTURE US PAYER LANDSCAPE FOR LIQUID BIOPSY-BASED ONCOLOGY SOMATIC MUTATION PANELS von Carlow, D., Infante, K., Manger, M., Nash, C.

Volltext

PCN237 ADOPTION AND UPTAKE OF LIQUID BIOPSY-BASED NSCLC SOMATIC MUTATION TESTING IN THE US CLINICAL SETTING von Carlow, D., Infante, K., Levent, A., Manger, M., Nash, C.

Volltext

PMU82 Increasing Importance of Digital CME in a Post COVID-19 World von Eslami, N., Infante, K., Harris, B., Erickson, G., Hoyvald, C., Garfield, S.

Volltext

PCN70 - Oncology Combination Pricing: Impact of Product Characteristics and Unmet Need von Madhavan, P, Infante, K, Harris, B, Nash, C

Volltext

Oncology Combination Pricing: Impact of Number of Competitors and Ownership Dynamics von Madhavan, P, Infante, K, Harris, B, Nash, C

Volltext

PCN71 - Oncology Combination Pricing: Impact of Number of Competitors and Ownership Dynamics von Madhavan, P, Infante, K, Harris, B, Nash, C

Volltext

Oncology Combination Pricing: Impact of Product Characteristics and Unmet Need von Madhavan, P, Infante, K, Harris, B, Nash, C

Volltext

MANUFACTURER REGULATORY SUBMISSION STRATEGIES FOR ONCOLOGY THERAPIES IN THE UNITED STATES AND EUROPEAN UNION, 2012-2016 von Madhavan, P, Jun, K, Infante, K, Richardson, SK

Volltext